Top

Published in:

01-04-2006 | Case Report

Ductal Carcinomain-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography

Authors: Tetsuhiro Owaki, Yuko Kijima, Heiji Yoshinaka, Yoshikazu Uenosono, Takako Yoshioka, Shoji Natsugoe, Takashi Aikou

Published in: Breast Cancer | Issue 2/2006

Title: Ductal Carcinomain-situ of the breast detected by [F-18] fluorodeoxyglucose positron emission tomography
Authors: Tetsuhiro Owaki
Yuko Kijima
Heiji Yoshinaka
Yoshikazu Uenosono
Takako Yoshioka
Shoji Natsugoe
Takashi Aikou
Publication date: 01-04-2006
Publisher: Springer-Verlag
Published in: Breast Cancer / Issue 2/2006
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.2325/jbcs.13.210

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2006

A case of breast carcinoma with cartilaginous and osseous metaplasia

Who benefits from hormone therapy?

Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer

Activation of PI3K/Akt signaling and hormone resistance in breast cancer

Results of a questionnaire survey for symptom of late complications caused by radiotherapy in breast conserving therapy

Investigation of factors related to periods to ipsilateral breast tumor recurrence after breast-conserving surgery and measures for preventing recurrence in early breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer